Company Overview
About Noetik
Noetik is a San Francisco AI-native biotech founded 2022. Builds foundation models simulating tumor biology for cancer immunotherapy drug discovery. Maps tumor microenvironment interactions to identify therapeutic targets.
Business Model & Competitive Advantage
Raised $62M: $14M seed (2023) and $40M Series A (2024, Polaris Partners). Early 2026: landmark $50M GSK deal (upfront + milestones) for nonexclusive license to NSCLC and colorectal cancer models. Also partnered with Agenus (2025).
Competitive Landscape 2025–2026
Validates AI licensing model for tech-bio: building foundation models that pharma partners use for drug discovery.
Open Positions
Reddit Discussions
Key Differentiators
Emerging Innovator
Noetik is an emerging player bringing innovative solutions to the Healthcare Tech market.
Frequently Asked Questions
Compare Noetik with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Start Comparison →Claim This Profile
Are you from Noetik? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Noetik Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Noetik vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →